← Back to Search

Rehabilitation for Shoulder Osteoarthritis (RTSA Trial)

N/A
Recruiting
Research Sponsored by HealthPartners Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
55 years of age
Candidate for a primary reverse total shoulder arthroplasty
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

RTSA Trial Summary

This trial will compare the effects of two different post-operative rehabilitation programs for people who have had a reverse shoulder arthroplasty.

Who is the study for?
This trial is for individuals aged 55 or older who need a primary reverse total shoulder arthroplasty, can fill out questionnaires themselves, and speak English. They must be able to attend follow-up visits and give informed consent. Exclusions include prior shoulder surgeries, infections, bleeding disorders, uncontrolled diabetes (HbA1C > 7.5%), major illnesses with life expectancy under 2 years, tobacco use within the last 8 weeks, drug/alcohol abuse.Check my eligibility
What is being tested?
The study tests immediate active shoulder rehabilitation versus traditional post-operative rehab after reverse total shoulder arthroplasty. It aims to compare clinical outcomes like pain relief and range of motion improvements as well as complications and cost-effectiveness over one year.See study design
What are the potential side effects?
While specific side effects are not listed for the rehabilitative interventions being tested in this trial, general risks may include discomfort during exercises, potential strain on healing tissues leading to inflammation or injury if not performed correctly.

RTSA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 55 years old or older.
Select...
I am a candidate for shoulder replacement surgery.

RTSA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
American Society for Elbow and Shoulder Score
PROMIS Global 10
Range of Motion
+1 more
Secondary outcome measures
Subscapularis Tear
Other outcome measures
Number of PT Visits

RTSA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate Active Shoulder RehabilitationExperimental Treatment1 Intervention
Group II: Traditional Should RehabilitationActive Control1 Intervention

Find a Location

Who is running the clinical trial?

HealthPartners InstituteLead Sponsor
185 Previous Clinical Trials
3,716,057 Total Patients Enrolled
TRIA Orthopaedic CenterOTHER
3 Previous Clinical Trials
946 Total Patients Enrolled

Media Library

Rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT03804853 — N/A
Shoulder Osteoarthritis Research Study Groups: Traditional Should Rehabilitation, Immediate Active Shoulder Rehabilitation
Shoulder Osteoarthritis Clinical Trial 2023: Rehabilitation Highlights & Side Effects. Trial Name: NCT03804853 — N/A
Rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03804853 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase of this trial still open?

"Per the information shared on clinicaltrials.gov, this research is recruiting currently. It was publicly posted in December 2018 and last updated at the end of February 2022."

Answered by AI

How many participants are involved with this medical investigation?

"Affirmative, the information from clinicaltrials.gov confirms that this medical trial is actively recruiting contributors. The study was first posted on December 12th 2018 and recently updated on February 28th 2022. 74 patients are needed to be recruited at a single site."

Answered by AI
~8 spots leftby Dec 2024